Sarah A Cook (Anna V Tinker)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Therapeutic advances in medical oncology

Journal of gynecologic oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

British Columbia Cancer Agency

This page only lists publications with an associated author ORCID identifier.

Affiliation History

British Columbia Cancer Agency Sep 05 2006

Canada

Medical Oncologist :: Systemic Therapy

Publications

Ana Carolina Veneziani, Clare Scott, Matthew J Wakefield, Sarah A Cook, Stephanie Lheureux
Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer. Therapeutic advances in medical oncology 15 (2023)
Todd M Bauer, Kathleen M Moore, Janet S Rader, Fiona Simpkins, Alain C Mita, J Thaddeus Beck, Lowell Hart, Quincy Chu, Amit Oza, Sarah A Cook, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Siqing Fu
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. Targeted oncology (2023)
Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, Renaud Sabatier, Jubilee Brown, Sharad A Ghamande, Cara A Mathews, David M O'Malley, Rebecca S Kristeleit, Valentina Boni, Adriano Gravina, Susana Banerjee, Rowan E Miller, Joanna Pikiel, Mansoor Raza Mirza, Ninad Dewal, Grace Antony, Yuping Dong, Eleftherios Zografos, Jennifer T Veneris, Sarah A Cook
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ana Carolina Veneziani, Clare Scott, Matthew J Wakefield, Sarah A Cook, Stephanie Lheureux
Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer. Therapeutic advances in medical oncology 15 (2023)
Sarah A Cook, Neesha C Dhani, Prafull Ghatage, Deanna McLeod, Vanessa Samouëlian, Stephen A Welch, Alon D Altman
A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer. Therapeutic advances in medical oncology 15 (2023)
Sarah A Cook, Neesha C Dhani, Prafull Ghatage, Deanna McLeod, Vanessa Samouëlian, Stephen A Welch, Alon D Altman
A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer. Therapeutic advances in medical oncology 15 (2023)
Ryan Urban, Justin Wong, Peter Lim, Susan Zhang, Ingrid Spadinger, Robert J Olson, Francois Bachand, Clement Ho, Sarah A Cook, Lovedeep Gondara, Sarah Nicole Hamilton
Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy. Journal of gynecologic oncology 33 (5) (2022)
Sarah Nicole Hamilton, Sarah A Cook, Janice S Kwon, Peter Lim, Iwa Kong, Sona Sihra, Martin Koebel, Cheng-Han Lee
Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma. Journal of gynecologic oncology 33 (3) (2022)
Janice S Kwon, Sarah A Cook, Jennifer Santos, Katie Compton, Sophie Sun, Kasmintan A Schrader, Aly Karsan
Germline Testing and Somatic Tumor Testing for <i>BRCA1/2</i> Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing? JCO precision oncology 6 (2022)
Pauline Krämer, Aline Talhouk, Mary Anne Brett, Derek S Chiu, Evan S Cairns, Daniëlla A Scheunhage, Rory F L Hammond, David A Farnell, Tayyebeh M Nazeran, Marcel Grube, Zhouchunyang Xia, Janine Senz, Samuel Leung, Lukas Feil, Jana Pasternak, Katherine Dixon, Andreas Hartkopf, Sara Brucker, Florian Heitz, Andreas du Bois, Philipp Harter, Felix K F Kommoss, Hans-Peter Sinn, Sabine Heublein, Hans-Walter Vollert, Ranjit Manchanda, Cornelis D de Kroon, Hans W Nijman, Marco de Bruyn, Emily F Thompson, Ali Bashashati, Jessica Nell McAlpine, Naveena Singh, Sarah A Cook, Annette Staebler, Tjalling Bosse, Martin Koebel, Michael S Anglesio
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Sarah A Cook, Anna V Tinker
PARP Inhibitors and the Evolving Landscape of Ovarian Cancer Management: A Review. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (3) (2019)

Sarah A Cook.css-eqlu8i{font-size:small;padding-left:4px;} (Anna V Tinker)

Publication Activity (10 Years)

Top Topics

Top Venues

Sarah A Cook (Anna V Tinker)